Anton Henssen, M.D.Cancer biologist, pediatric oncology fellow and conceptual artist
He studied medicine in Düsseldorf and Paris and did his doctoral thesis in neuroscience at the Helmholtz Jülich Research Centre and the RWTH Aachen University. He did his postdoctoral research fellowship in cancer biology at the Memorial Sloan Kettering Cancer Center in New York with Dr. Alex Kentsis and Scott Armstrong. In 2018 he started his Emmy Noether Research Group at the Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin.
Konstantin HelmsauerMedical student at Charité Berlin
He focuses on the computational analysis of (epi)genomic data to investigate how circular DNA and other genomic structural aberrations affect gene regulation in neuroblastoma. He is supported by a doctoral scholarship from Berliner Krebsgesellschaft e.V.
Yi BeiM.Sc. is a cancer biologist
He did his Bachelor in Biological Science in China and did a Master in Molecular Medicine in Germany, and is doing his PhD thesis in the group. He is focusing on identifying novel synthetic lethal partner in MYCN amplified neuroblastoma.
She is a trained biochemist and molecular biologist. After studying biochemistry in Leipzig, she performed her doctoral thesis in cancer research at the Fraunhofer Institute for Cell Therapy and Immunology/University of Leipzig. She joined the German Cancer Consortium in 2014 and worked as Post-Doc in the Institute of Pathology at the Charité in the group of Prof. Christine Sers. Since October 2018 she is a member of the Henssen group.
Victor BardinetPediatric resident
After studying medicine in Bordeaux (France) and Berlin, he joined the group to do his medical thesis. He is working on the molecular characterisation of rhabdomyosarcoma PDX-models concernin chemoresistance, in order to better predict the patient’s responses to treatment in clinical practice. He got the “Ernst von Leyden” scholarship from the Berliner Krebsgesellschaft to achieve this work.
Heathcliff Dorado GarcíaM.Sc. is a biotechnologist and cancer biologist
He studied in Salamanca (Spain) and Berlin, and is currently doing his doctoral thesis in the group. He was awarded with a fellowship from “la Caixa” in 2018 to support his work. His focus is the identification of new vulnerabilities in rhabdomyosarcoma in the context of DNA damage and genomic instability.
Rocío Chamorro GonzálezPhD student
She studied Biochemistry at the University of Málaga and did a master in Molecular Medicine at Charité – University Hospital of Berlin. She studies genetic diversity in neuroblastoma and its implication in clinical outcome and also focuses on understanding the role of circular DNA in tumor adaptation to therapy.
Jennifer von StebutMedical student at Charité Berlin
She focuses on understanding the mechanisms of resistance against actinomycin D in rhabdomyosarcoma. She is currently supported by the BIH-MD scholarship for her time in the lab.
Claudia RöefzaadTechnicial Assistant
After studying biotechnology at the TFH Berlin, she worked in molecular- biology- laboratories of various research groups of the ECRC/Charité.
Natalie TimmeMedical student at Charité Berlin
She focuses on the testing of new protein inhibitors in the treatment of rhabdomyosarcoma.
Youjia HanMedical student at Charité Berlin
She investigates new treatment options for medulloblastoma.